Filing Details
- Accession Number:
- 0001179110-15-001556
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-03 14:37:57
- Reporting Period:
- 2015-02-02
- Filing Date:
- 2015-02-03
- Accepted Time:
- 2015-02-03 14:37:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1436304 | Kythera Biopharmaceuticals Inc | KYTH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1354034 | D Camille Samuels | C/O Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, Suite 300 Westlake Village CA 91362 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-02-02 | 250 | $37.31 | 15,435 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to the Reporting Person's 10b5-1 plan which expires December 31, 2015.
- The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $37.21 to $37.38, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.